DexCom, Inc. (DXCM)财务
NASDAQ · Healthcare · Medical - Devices · 员工11,050人 · CEO Jacob Steven Leach
- 股价
- $82.29 +2.95%
- 市值
- $307亿
- 企业价值
- $311亿
- 最近财报
- Q3 '26 2026-10-29提交
- 下次财报
- 2027-02-11 EPS预期 $0.72
估值与关键数据
- 市值
- $307亿 EV $311亿
- 营收
- $51亿 过去12个月
- 营收增速
- +12% FY2026年一致预期
- 净利润率
- 19.4% 净利润 / 营收,TTM
- P/E
- 31.8× 预期 30.5×(FY2026)
- P/S
- 6.0× 股价 / 营收,TTM
- EV / EBITDA
- 20.1× TTM
- 自由现金流
- $11亿 过去12个月
- 净利润
- $9.91亿 过去12个月
- 营收预期
- $52.3亿 FY2026年一致预期
- 盈利
- 2027-02-11 营收预期 $13.8亿
- 股息
- – 无股息
核心要点
根据披露数据计算,每条结论都附有其依据的数字。
- 最近财报(2026-10-29):营收超预期1.2%,EPS 超预期8.1%营收$13.4亿,预期$13.3亿(+1.2%);EPS $0.73,预期$0.68(+8.1%)。
- 营收增长放缓:同比11.2%Q3 '26营收$13.4亿,此前四个季度的平均值为15.7%。
- 营业利润率24.0%(TTM),较去年同期+6.8 百分点营收增长13.0%,营业利润增长57.4%。
- 资本支出占营收的6.2%(去年为8.6%)最近4个季度投入$3.16亿(同比-18.2%)。自由现金流$11亿,相当于净利润的110.8%。
- 股东回报$13.2亿 = 自由现金流的119.9%回购$13.2亿(去年为$1.87亿),股息$0,股权激励$1.54亿(TTM)。 超过自由现金流:由现金储备或举债支付。
- 稀释股数一年内减少5.9%Q3 '26稀释股数3.84亿,一年前为4.07亿。
- 净现金 $4.25亿现金 + 短期投资 $18.2亿,含租赁债务 $13.9亿;一年前净现金 $7.47亿。
上一季度:Q3 '26
截至2026-09-30的季度。与去年同期及财报发布前的分析师一致预期对比。
本季度与去年同期
| Q3 '26 | 去年同期 | 变化 | |
|---|---|---|---|
| 营收 | $13.4亿 | $12.1亿 | +11.2% |
| 毛利率 | 64.3% | 60.5% | +3.8 百分点 |
| 营业利润 | $3.27亿 | $2.43亿 | +34.9% |
| 营业利润率 | 24.3% | 20.1% | +4.3 百分点 |
| 净利润 | $2.75亿 | $2.84亿 | -3.1% |
| 稀释EPS | $0.72 | $0.70 | +2.9% |
| 经营现金流 | $3.26亿 | $6.6亿 | -50.7% |
| 资本支出 | $5290万 | $8050万 | -34.3% |
| 自由现金流 | $2.73亿 | $5.79亿 | -52.9% |
| R&D | $1.62亿 | $1.58亿 | +2.6% |
| 股权激励费用 | $3680万 | $4510万 | -18.4% |
实际 vs 一致预期
2026-10-29| 实际 | 一致预期 | 对比预期 | |
|---|---|---|---|
| 营收 | $13.4亿 | $13.3亿 | +1.2% |
| EPS(一致预期口径) | $0.73 | $0.68 | +8.1% |
来自2026-10-29发布的Q3 '26财报:营收及分析师预期口径的EPS(通常为调整后),可能与上方报表中的EPS不同。
EPS与一致预期
最近8次财报营收
收入从何而来,按业务线和地区逐季展示。
营收、营业利润与增速
季度按业务线划分的营收
堆叠,季度| 分部 | Q3 '26 | 同比 | 占比 | TTM | TTM同比 | 12个季度 |
|---|---|---|---|---|---|---|
| Reportable Segment | $13.4亿 | – | 100.0% | – | – |
按地区划分的营收
占总额比例| 分部 | Q3 '26 | 同比 | 占比 | TTM | TTM同比 | 12个季度 |
|---|---|---|---|---|---|---|
| Non-US | $3.75亿 | +4.8% | 100.0% | $14.8亿 | – |
分部利润
取自每份10-Q / 10-K分部附注的各披露分部营业利润(多数数据源缺少的利润拆分)。
Q3 '26分部
| 分部 | 营收 | 同比 | 营业利润 | 同比 | 利润率 | 去年同期利润率 | TTM营业利润 |
|---|---|---|---|---|---|---|---|
| Reportable Segment | $13.4亿 | – | $3.27亿 | – | 24.3% | – | – |
各分部营业利润
季度各分部营业利润率
季度利润率与成本结构
每一单位营收在各层级还剩多少,成本又花在哪里。
利润率
季度成本占营收比例
季度现金流与资本配置
创造了多少现金,用在何处,又有多少回到股东手中。
经营现金流、资本支出、自由现金流
季度现金用途与经营现金流
财年最近4个季度
现金流量表- 经营现金流
- $14.1亿
- 资本支出
- -$3.16亿
- 股票回购
- -$13.2亿
- 股息
- $0
- 收购
- $0
- 债务净发行
- $0
- 股权激励费用
- $1.54亿
- 自由现金流
- $11亿
- 股东回报 / FCF
- 119.9%
股数与EPS
季度,稀释资产负债表
各季度末的流动性、投资和债务。
现金、投资与债务
季度末估值与回报
当前估值倍数与公司自身过去五个财年对比;分析师目标价与评级。
估值倍数与回报
TTM与过去5个财年| 当前 | 5年均值 | 当前处于5年区间的位置 | |
|---|---|---|---|
| P/E(TTM) | 31.8× | 107.8× | 31.0× – 239.7× |
| EV / EBITDA | 20.1× | 66.1× | 19.4× – 140.5× |
| EV / 营收 | 6.1× | 13.0× | 5.7× – 21.7× |
| 股价 / FCF | 27.9× | 257.3× | 24.0× – 974.4× |
| 股价 / 净资产 | 12.2× | 18.7× | 9.4× – 25.4× |
| FCF收益率 | 3.6% | 1.6% | 0.1% – 4.2% |
| 投入资本回报率 | 24.0% | 9.9% | 5.3% – 16.6% |
| 净资产收益率 | 36.5% | 22.1% | 10.6% – 30.5% |
分析师
一致目标价 $97.85 (+18.9%)
区间 $86.00 – $115.00 · 评级 Buy
展望
分析师对未来财年的一致预期,以及按当前股价意味着什么。
一致预期
| 财年 | 营收 | 增速 | EPS | 增速 | 按当前股价的P/E | 分析师(EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $52.3亿 | +12.2% | $2.70 | +29.2% | 30.5× | 13 |
| FY2027 | $57.7亿 | +10.3% | $3.13 | +15.9% | 26.3× | 15 |
| FY2028 | $64.1亿 | +11.1% | $3.71 | +18.6% | 22.2× | 7 |
| FY2029 | $70.9亿 | +10.5% | $4.28 | +15.3% | 19.2× | 2 |
| FY2030 | $78.2亿 | +10.4% | $4.95 | +15.7% | 16.6× | 4 |
财务报表
利润表、资产负债表和现金流量表的每一项,含12个季度和10个财年,以金额、占营收比例或增速展示。
全部披露项目
DexCom, Inc.在近期10-Q / 10-K文件中标记的全部267项数据,附SEC官方标签和定义,包括附注(租赁、税务、回购、员工等)。
| 项目(SEC标签) | 最近季度 | 去年同期 | 同比 | 最近财年 | 上一财年 | 同比 |
|---|---|---|---|---|---|---|
| Accounts Payable and Other Accrued Liabilities, Current | $20.7亿 | $19.3亿 | +6.9% | $19.4亿 | $15.9亿 | +22.6% |
| Accounts Payable, Trade, Current | $3.09亿 | $4.52亿 | -31.7% | $3.44亿 | $3.45亿 | -0.3% |
| Accounts Receivable, after Allowance for Credit Loss | $12.2亿2025-12-31 | $10.1亿 | +20.9% | $12.2亿 | $10.1亿 | +20.9% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $11.9亿 | $11.1亿 | +6.9% | $12.2亿 | $10.1亿 | +20.9% |
| Accounts Receivable, Allowance for Credit Loss | $1250万2025-12-31 | $920万 | +35.9% | $1250万 | $920万 | +35.9% |
| Accounts Receivable, before Allowance for Credit Loss | $12.3亿2025-12-31 | $10.1亿 | +21.1% | $12.3亿 | $10.1亿 | +21.1% |
| Accrued Employee Benefits, Current | $2870万 | $2830万 | +1.4% | $3460万 | $3750万 | -7.7% |
| Accrued Income Taxes, Current | $2560万 | $680万 | +276.5% | $890万 | $390万 | +128.2% |
| Accrued Income Taxes, Noncurrent | $4660万2025-12-31 | $4480万 | +4.0% | $4660万 | $4480万 | +4.0% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $8550万 | $8150万 | +4.9% | $1.15亿 | -$800万 | +1,537.5% |
| Additional Paid in Capital, Common Stock | $24.3亿 | $22.5亿 | +8.0% | $22.8亿 | $20.9亿 | +9.0% |
| Advertising Expense | – | – | – | $2.24亿 | $1.94亿 | +15.2% |
| Amortization of Debt Issuance Costs | $100万 | $180万 | -44.4% | $700万 | $720万 | -2.8% |
| Amortization of Intangible Assets | – | – | – | $420万 | $670万 | -37.3% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $3680万 | $4510万 | -18.4% | $1.6亿 | $1.7亿 | -6.3% |
| Asset Retirement Obligation | $1990万 | $1760万 | +13.1% | $2060万 | $1700万 | +21.2% |
| Assets | $62.4亿 | $75亿 | -16.8% | $63.4亿 | $64.8亿 | -2.2% |
| Assets, Current | $39.2亿 | $52.2亿 | -25.0% | $40.3亿 | $43亿 | -6.2% |
| Assets, Fair Value Disclosure | $18.7亿2026-03-31 | $21.9亿 | -14.7% | $15亿 | $21.4亿 | -29.7% |
| Cash and Cash Equivalents, at Carrying Value | $9.61亿 | $18.4亿 | -47.6% | $9.18亿 | $6.06亿 | +51.4% |
| Cash Equivalents, at Carrying Value | $5.38亿2026-03-31 | $3.63亿 | +48.4% | $3.93亿 | $1.34亿 | +192.7% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $9.62亿 | $18.4亿 | -47.7% | $9.19亿 | $6.07亿 | +51.3% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -$1.44亿 | $6.77亿 | -121.2% | $3.12亿 | $3980万 | +683.4% |
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | 0.0% | $0.00 | $0.00 | 0.0% |
| Common Stock, Shares Authorized | 8亿 | 8亿 | 0.0% | 8亿 | 8亿 | 0.0% |
| Common Stock, Shares, Issued | 4.13亿 | 4.11亿 | +0.5% | 4.11亿 | 4.09亿 | +0.4% |
| Common Stock, Shares, Outstanding | 3.73亿 | 3.9亿 | -4.4% | 3.85亿 | 3.91亿 | -1.5% |
| Common Stock, Value, Outstanding | $40万 | $40万 | 0.0% | $40万 | $40万 | 0.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $2.71亿 | $2.82亿 | -3.9% | $9.59亿 | $5.85亿 | +64.0% |
| Contract with Customer, Liability, Current | $290万2025-09-30 | $1390万 | -79.1% | $800万2024-12-31 | $1840万 | -56.5% |
| Contract with Customer, Liability, Noncurrent | $850万2025-09-30 | $520万 | +63.5% | $950万2024-12-31 | $740万 | +28.4% |
| Convertible Notes Payable, Current | $02025-12-31 | $12亿 | -100.0% | $0 | $12亿 | -100.0% |
| Convertible Notes Payable, Noncurrent | $12.4亿 | $12.4亿 | +0.3% | $12.4亿 | $12.4亿 | +0.3% |
| Cost of Goods and Services Sold | $4.8亿 | $4.78亿 | +0.5% | $18.6亿 | $15.9亿 | +16.6% |
| Current Federal Tax Expense (Benefit) | – | – | – | $3710万 | $1.57亿 | -76.4% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $2570万 | $270万 | +851.9% |
| Current Income Tax Expense (Benefit) | – | – | – | $6990万 | $1.77亿 | -60.4% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $710万 | $1650万 | -57.0% |
| Debt Conversion, Converted Instrument, Amount | – | – | – | $0 | $0 | – |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | $0 | $180万 | -100.0% | $160万 | $170万 | -5.9% |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | $340万 | $20万 | +1,600.0% | $0 | $110万 | -100.0% |
| Debt Securities, Realized Gain (Loss) | $02025-12-31 | $0 | – | $0 | $0 | – |
| DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss | $8.6亿 | $14.8亿 | -42.1% | $10.8亿 | $19.7亿 | -45.3% |
| DebtSecuritiesAvailableForSaleExcludingAccruedInterest | $8.57亿 | $14.9亿 | -42.4% | $10.8亿 | $19.7亿 | -45.2% |
| DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent | $7.23亿 | $14.1亿 | -48.7% | $10.8亿 | $17.3亿 | -37.6% |
| DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent | $1.34亿 | $7630万 | +75.1% | $2.48亿2024-12-31 | – | – |
| Deferred Compensation Liability, Current | $2180万 | $2050万 | +6.3% | $2000万 | $1860万 | +7.5% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | $1.7亿 | -$5520万 | +407.4% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | -$350万 | $1340万 | -126.1% |
| Deferred Income Tax Assets, Net | $3.05亿 | $3.76亿 | -18.7% | $2.96亿 | $4.81亿 | -38.6% |
| Deferred Income Tax Expense (Benefit) | -$90万 | $1.18亿 | -100.8% | $1.82亿 | -$4380万 | +516.0% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | $1600万 | -$200万 | +900.0% |
| Deferred Tax Assets, Gross | $5.08亿2025-12-31 | $7.48亿 | -32.1% | $5.08亿 | $7.48亿 | -32.1% |
| Deferred Tax Assets, in Process Research and Development | $1.04亿2025-12-31 | $2.65亿 | -60.9% | $1.04亿 | $2.65亿 | -60.9% |
| Deferred Tax Assets, Net | $2.83亿2025-12-31 | $4.67亿 | -39.4% | $2.83亿 | $4.67亿 | -39.4% |
| Deferred Tax Assets, Net of Valuation Allowance | $3.47亿2025-12-31 | $5.26亿 | -34.0% | $3.47亿 | $5.26亿 | -34.0% |
| Deferred Tax Assets, Operating Loss Carryforwards | $1260万2025-12-31 | $1440万 | -12.5% | $1260万 | $1440万 | -12.5% |
| Deferred Tax Assets, Tax Credit Carryforwards | $8560万2025-12-31 | $7920万 | +8.1% | $8560万 | $7920万 | +8.1% |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | $2060万2025-12-31 | $2250万 | -8.4% | $2060万 | $2250万 | -8.4% |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | $8680万2025-12-31 | $8740万 | -0.7% | $8680万 | $8740万 | -0.7% |
来源:SEC companyfacts(每份10-Q / 10-K的XBRL)。现金流量表的季度数据由10-Q标记的年初至今累计数推算。分部拆分带有维度标记,在分部章节中单独展示。
数据来源
报表、分部营收、指标和预期均根据公司文件标准化。分部利润及全部披露项目:SEC EDGAR(XBRL)。 已读取的文件: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
数据截至 2026-11-02